We Now Offer ONCOblot Cancer Screen Test

ONCOblot cancer screen test
The ONCOblot Test allows doctors to more accurately understand a patient’s medical condition.

Many patients are hesitant about paying for medical services that may or may not meet their expectations, especially when it comes to detecting serious diseases or conditions. That’s exactly the type of fear two patients of Longevity and Stem Cell Centre of Houston had prior to undergoing a ONCOblot cancer screen test.

“The non-invasive test identifies abnormalities in the body that may signify a person has cancer.”

The ONCOblot Test is a single blood test that can provide doctors with more accurate stories regarding people’s medical conditions.

For example, in the case of cancer, the test can discover the disease by identifying the ENOX2 protein – a substance that is produced in the presence of cancer. The non-invasive test identifies abnormalities in the body that may signify a person has cancer.

The ONCOblot Test can confirm over 25 cancers such as bladder, breast, gastric, kidney, leukemia, small cell lung, myeloma, prostate and ovarian.

Further the ONCOblot Test can complement existing procedures such as irregular mammograms, doubtful PET scans and abnormally high prostate-specific antigens.

Doctors can also use it to test for traces of diseases two months after patients have undergone treatment.

But despite these benefits, some patients still fear the unknown until they’ve spoken to a professional who performs the ONCOblot Test.

As we previously mentioned, a gentlemen who scheduled an appointment with Longevity Centres was unsure if his mildly high PSA was due to a benign enlargement or cancer. He was skeptical about undergoing a biopsy for fear of possible complications and the fact the biopsy may miss the actual tumor and give a false negative result.

Dr. Pearsall of Longevity Centres convinced the patient to take the ONCOblot Test, and it showed positive results. The patient felt more comfortable having a biopsy, which also returned positive results, and he was able to catch the disease early.

In another case, a female patient of Longevity Centre was experiencing post-menopausal bleeding and felt doubtful about undergoing a uterine biopsy because she questioned whether it would cause complications and provide accurate results.

After talking to Longevity Centres, she felt more confident in undergoing the ONCOblot Test, and results came back negative. This allowed her to take a more conservative approach to her treatment and avoid an invasive and unnecessary biopsy.

For those who have cancer, this test has enabled doctors to catch the disease as early as stage 0 and enables doctors to confirm the presence of cancer cells despite the small amount of ENOX2 protein these cells typically release (roughly 2 million).

Longevity Centres believes this is a very useful, ground breaking test that has enabled us to better understand patient conditions and detect complications before they become serious or even fatal. It has also allowed patients to make more informative choices regarding the type of treatments they schedule.

However, it should be used in conjunction with other scheduled medical exams, appointments or processes.

Further, when scheduling a ONCOblot cancer screen test, make sure you’ve compiled a detailed medical history of your health and the specific condition in question.

This will allow us to develop a more complete picture of the situation and ensure more accurate results are recorded, thus allowing us to provide more accurate treatment recommendations.